TIMOTHY BERGER: Open Payments
NPI 1124079181 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$38,388 in 17 payments from 5 companies in 2025. Trend: 2023 $111,319 · 2024 $31,180 · 2025 $38,388
Speaker / faculty: $21,350Consulting: $14,880Travel & lodging: $1,846Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 4 | $12,581 |
| GENZYME CORPORATION | 8 | $12,129 |
| Regeneron Healthcare Solutions, Inc. | 3 | $11,175 |
| Novartis Pharmaceuticals Corporation | 1 | $2,475 |
| Blueprint Medicines Corporation | 1 | $29 |
Products named: NEMLUVIO, DUPIXENT.
Industry payments across CA — which companies pay providers there.
